Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A fourth pillar for evidence-based medicine: implications for psychiatry - CORRIGENDUM.

The British journal of psychiatry : the journal of mental science·2026

Same author

A fourth pillar for evidence-based medicine: implications for psychiatry.

The British journal of psychiatry : the journal of mental science·2026

Same author

Diagnostic Yield of Post-Mortem Fetal Micro-CT for Central Nervous System Abnormalities.

Prenatal diagnosis·2026

Same author

Germline duplication of MYCN predisposes to childhood embryonal tumours.

EBioMedicine·2026

Same author

Diagnostic Yield of Post-Mortem Fetal Micro-CT for Abdominal and Pelvic Anomalies.

Prenatal diagnosis·2026

Same author

A platform for generating clinical intelligence from routine health data in hospitals: PICTURE.

Future healthcare journal·2026

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

ERG is a megakaryocytic oncogene.

Samira Salek-Ardakani¹, Gil Smooha, Jasper de Boer

¹Molecular Haematology and Cancer Biology Unit, University College London Institute of Child Health and Great Ormond Street Hospital for Children, London, United Kingdom.

Cancer Research

|June 3, 2009

Summary

Ets-related gene (ERG) promotes megakaryopoiesis and acts as an oncogene, causing leukemia in mice. ERG is essential for acute megakaryoblastic leukemia (AMKL) cell lines and cooperates with GATA1s in Down syndrome AMKL.

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

Related Experiment Videos

Last Updated: Jun 22, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

Area of Science:

Hematology
Molecular Biology
Oncology

Background:

Ets-related gene (ERG) is an ETS transcription factor crucial for hematopoiesis and megakaryopoiesis.
Truncated ERG variants are implicated in various cancers, including leukemia.
High ERG expression correlates with poor prognosis in acute myeloid leukemia (AML).

Purpose of the Study:

To investigate the leukemogenic potential of Ets-related gene (ERG) expression.
To determine ERG's role in acute megakaryoblastic leukemia (AMKL) pathogenesis.
To explore ERG's cooperation with GATA1s in Down syndrome AMKL.

Main Methods:

Ectopic expression of ERG in fetal hematopoietic progenitors.
In vivo leukemia induction in mice.
Assessment of endogenous ERG requirement in AMKL cell lines.
Co-expression studies with mutated GATA1s.

Main Results:

Ectopic ERG expression in progenitors promoted megakaryopoiesis and induced rapid leukemia in vivo.
Endogenous ERG is essential for AMKL cell line proliferation and maintenance.
ERG cooperates with GATA1s to immortalize megakaryocyte progenitors, suggesting a role in trisomy 21-associated AMKL.

Conclusions:

Ets-related gene (ERG) functions as a potent hematopoietic oncogene.
ERG plays a direct role in myeloid leukemia pathogenesis.
ERG may contribute to the development of Down syndrome AMKL.